TickerFacts.

QTREX Quantum Ltd. (QTEX): Cost of Revenue

Annual figures by period end, from SEC filings.

$287.0K
Year ended 2025-12-31
2023-12-31: $02024-12-31: $02025-12-31: $287.0K$287.0K
2023-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$287.0Kn/a2026-03-26, From 2025-01-01
2024-12-31$0n/a2026-03-26, From 2024-01-01
2023-12-31$0n/a2026-03-26, From 2023-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
QTREX Quantum Ltd. (QTEX)2025-12-31$287.0Kn/a
Pulse Biosciences, Inc. (PLSE)2025-12-31$539.0Kn/a
Co-Diagnostics, Inc. (CODX)2025-12-31$222.4K-77.7%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31$646.0K+139.3%
Catheter Precision, Inc. (VTAK)2025-12-31$63.0K+50.0%
Sintx Technologies, Inc. (SINT)2025-12-31$557.0K-31.3%
RenovoRx, Inc. (RNXT)2025-12-31$327.0Kn/a
PetVivo Holdings, Inc. (PETV)2026-03-31$386.9K+181.0%
Vivos Inc (RDGL)2025-12-31$128.1K+313.6%

Compare QTEX, PLSE, CODX, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗